Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anricafen dose-finding, safety, and comfort in moderate postoperative pain
ChiCTR2600117028Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine hydrochloride + flurbiprofen axetil in postoperative pain (3 arms), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoints: Safety and comfort and ED90 / ED?? Planned start Jan 2026; status: not yet recruiting.
02
Drugs
nalbuphine hydrochloride + flurbiprofen axetil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600117028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600117028.